Literature DB >> 8668150

Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.

N Vu-Dac1, K Schoonjans, V Kosykh, J Dallongeville, R A Heyman, B Staels, J Auwerx.   

Abstract

Considering the link between plasma high-density lipoprotein (HDL) cholesterol levels and a protective effect against coronary artery disease as well as the suggested beneficial effects of retinoids on the production of the major HDL apolipoprotein (apo), apo A-I, the goal of this study was to analyze the influence of retinoids on the expression of apo A-II, the other major HDL protein. Retinoic acid (RA) derivatives have a direct effect on hepatic apo A-II production, since all-trans (at) RA induces apo A-II mRNA levels and apo A-II secretion in primary cultures of human hepatocytes. In the HepG2 human hepatoblastoma cell line, both at-RA and 9-cis RA as well as the retinoid X receptor (RXR)-specific agonist LGD 1069, but not the RA receptor (RAR) agonist ethyl-p-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-l-pro penyl]-benzoic acid (TTNPB), induce apo A-II mRNA levels. Transient-transfection experiments with a reporter construct driven by the human apo A-II gene promoter indicated that 9-cis RA and at-RA, as well as the RXR agonists LGD 1069 and LG 100268, induced apo A-II gene expression at the transcriptional level. Only minimal effects of the RAR agonist TTNPB were observed on the apo A-II promoter reporter construct. Unilateral deletions and site-directed mutagenesis identified the J site of the apo A-II promoter mediating the responsiveness to RA. This element contains two imperfect half-sites spaced by 1 oligonucleotide. Cotransfection assays in combination with the use of RXR or RAR agonists showed that RXR but not RAR transactivates the apo A-II promoter through this element. By contrast, RAR inhibits the inductive effects of RXR on the apo A-II J site in a dose-dependent fashion. Gel retardation assays demonstrated that RXR homodimers bind, although with a lower affinity than RAR-RXR heterodimers, to the AH-RXR response element. In conclusion, retinoids induce hepatic apo A-II production at the transcriptional level via the interaction of RXR with an element in the J site containing two imperfect half-sites spaced by 1 oligonucleotide, thereby demonstrating an important role of RXR in controlling human lipoprotein metabolism. Since the J site also confers responsiveness of the apo A-II gene to fibrates and fatty acids via the activation of peroxisome proliferator-activated receptor-RXR heterodimers, this site can be considered a plurimetabolic response element.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668150      PMCID: PMC231329          DOI: 10.1128/MCB.16.7.3350

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.

Authors:  R Apfel; D Benbrook; E Lernhardt; M A Ortiz; G Salbert; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 2.  Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling.

Authors:  V Giguère
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

3.  Retinoids stimulate ApoA-I synthesis by induction of gene transcription in primary hepatocyte cultures from cynomolgus monkey (Macaca fascicularis)

Authors:  A Kaptein; E C de Wit; H M Princen
Journal:  Arterioscler Thromb       Date:  1993-10

4.  Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene.

Authors:  J P Bossu; F L Chartier; N Vu-Dac; J C Fruchart; B Laine
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

5.  Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.

Authors:  J R Schultz; J G Verstuyft; E L Gong; A V Nichols; E M Rubin
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

6.  Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic acid. Absence of effects on apolipoprotein A-II gene expression.

Authors:  L Berthou; B Staels; I Saldicco; K Berthelot; J Casey; J C Fruchart; P Denèfle; D Branellec
Journal:  Arterioscler Thromb       Date:  1994-10

7.  Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein.

Authors:  P Cardot; D Pastier; J M Lacorte; M Mangeney; V I Zannis; J Chambaz
Journal:  Biochemistry       Date:  1994-10-11       Impact factor: 3.162

8.  Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

Authors:  C C Hedrick; L W Castellani; C H Warden; D L Puppione; A J Lusis
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Homo- and heterodimers of the retinoid X receptor (RXR) activated transcription in yeast.

Authors:  D M Heery; B Pierrat; H Gronemeyer; P Chambon; R Losson
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

10.  Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.

Authors:  M F Boehm; L Zhang; B A Badea; S K White; D E Mais; E Berger; C M Suto; M E Goldman; R A Heyman
Journal:  J Med Chem       Date:  1994-09-02       Impact factor: 7.446

View more
  11 in total

1.  Effectiveness of vitamin A acetate for enhancing the production of lung cancer specific monoclonal antibodies.

Authors:  Y Inoue; M Fujisawa; S Kawamoto; M Shoji; S Hashizume; M Fujii; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

2.  Setting the course for apoAII: a port in sight?

Authors:  Henry J Pownall; Baiba K Gillard; Antonio M Gotto
Journal:  Clin Lipidol       Date:  2013-10

3.  Metabolism to a response pathway selective retinoid ligand during axial pattern formation.

Authors:  W W Pijnappel; G E Folkers; W J de Jonge; P J Verdegem; S W de Laat; J Lugtenburg; H F Hendriks; P T van der Saag; A J Durston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.

Authors:  H Y Lee; D F Dohi; Y H Kim; G L Walsh; U Consoli; M Andreeff; M I Dawson; W K Hong; J M Kurie
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Transcriptional activation by hepatocyte nuclear factor-4 in a cell-free system derived from rat liver nuclei.

Authors:  S Harish; T Khanam; S Mani; P Rangarajan
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

Review 6.  Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects.

Authors:  Aurélie Comptour; Marion Rouzaire; Corinne Belville; Damien Bouvier; Denis Gallot; Loïc Blanchon; Vincent Sapin
Journal:  Cell Mol Life Sci       Date:  2016-08-09       Impact factor: 9.261

7.  Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

Authors:  N Vu-Dac; P Gervois; I P Torra; J C Fruchart; V Kosykh; T Kooistra; H M Princen; J Dallongeville; B Staels
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

8.  PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Authors:  Maja Grabacka; Wojciech Placha; Krystyna Urbanska; Piotr Laidler; Przemysław M Płonka; Krzysztof Reiss
Journal:  Pigment Cell Melanoma Res       Date:  2008-04-26       Impact factor: 4.693

9.  Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor beta heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a.

Authors:  Eudoxia Hatzivassiliou; George Koukos; Agnes Ribeiro; Vassilis Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

10.  Differences in transcriptional activation by the two allelic (L162V Polymorphic) variants of PPARα after Omega-3 fatty acids treatment.

Authors:  Iwona Rudkowska; Mélanie Verreault; Olivier Barbier; Marie-Claude Vohl
Journal:  PPAR Res       Date:  2009-02-25       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.